Furthermore, it has also been shown that EGFR mutant type NSCLC tumors are significantly less sensitive to ICIs than EGFR wild type NSCLC tumors, and are more common in female patients than in male patients [81]. Here, EGFR is linked to non-small cell lung carcinoma.